Literature DB >> 11353947

The prevalence of familial hypocalciuric hypercalcemia.

J Hinnie1, E Bell, E McKillop, S Gallacher.   

Abstract

Familial hypocalciuric hypercalcemia is said to be an extremely rare condition but is clinically important because it can be confused with primary hyperparathyroidism. The biochemical features of the two conditions are similar, but the former is benign while the latter can have serious clinical consequences with patients occasionally proceeding to parathyroidectomy. It is therefore important to differentiate accurately between the two. With this in mind it would be useful to know the prevalence of familial hypocalciuric hypercalcemia when considering the differential diagnosis of primary hyperparathyroidism. However, as far as we are aware, no estimate of the prevalence of this condition can be found in the literature. We describe how an estimate was made of the prevalence of familial hypocalciuric hypercalcemia in the west of Scotland. We estimate the prevalence to be 1 in 78,000 at least.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11353947     DOI: 10.1007/s002230001201

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  15 in total

Review 1.  Parathyroid hormone-dependent hypercalcemia.

Authors:  Judit Toke; Attila Patócs; Katalin Balogh; Péter Gergics; Balázs Stenczer; Károly Rácz; Miklós Tóth
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 2.  Familial hypocalciuric hypercalcemia and related disorders.

Authors:  Janet Y Lee; Dolores M Shoback
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-05-26       Impact factor: 4.690

3.  Novel mutations of the calcium-sensing receptor impede differential diagnosis of primary hyperparathyroidism and familial hypocalciuric hypercalcemia.

Authors:  Jagdeep Singh Bhangu; Sabina Baumgartner-Parzer; Lindsay Hargitai; Peter Mazal; Christian Scheuba; Philipp Riss
Journal:  Gland Surg       Date:  2022-01

4.  A case report of familial benign hypocalciuric hypercalcemia: a mutation in the calcium-sensing receptor gene.

Authors:  Seong Ill Woo; Hyunju Song; Kyung Eun Song; Dae Jung Kim; Kwan Woo Lee; Se Joong Kim; Yoon-Sok Chung
Journal:  Yonsei Med J       Date:  2006-04-30       Impact factor: 2.759

5.  Calcium-sensing receptor signaling - How human disease informs biology.

Authors:  Caroline M Gorvin
Journal:  Curr Opin Endocr Metab Res       Date:  2020-07-02

6.  Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications.

Authors:  J Warner; M Epstein; A Sweet; D Singh; J Burgess; S Stranks; P Hill; D Perry-Keene; D Learoyd; B Robinson; P Birdsey; E Mackenzie; B T Teh; J B Prins; J Cardinal
Journal:  J Med Genet       Date:  2004-03       Impact factor: 6.318

7.  [Chondrocalcinosis revealing familial hypocalciuric hypercalcemia: about one observation].

Authors:  Faten Frikha; Mouna Snoussi; Raida Ben Salah; Hanen Loukil; Zouhir Bahloul
Journal:  Pan Afr Med J       Date:  2015-01-22

8.  Presentation, diagnostic assessment and surgical outcomes in primary hyperparathyroidism: a single centre's experience.

Authors:  Laura Reid; Bala Muthukrishnan; Dilip Patel; Mike Crane; Murat Akyol; Andrew Thomson; Jonathan R Seckl; Fraser Wilson Gibb
Journal:  Endocr Connect       Date:  2018-08-23       Impact factor: 3.335

9.  Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population.

Authors:  Ridge Dershem; Caroline M Gorvin; Raghu P R Metpally; Sarathbabu Krishnamurthy; Diane T Smelser; Fadil M Hannan; David J Carey; Rajesh V Thakker; Gerda E Breitwieser
Journal:  Am J Hum Genet       Date:  2020-05-07       Impact factor: 11.025

Review 10.  The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases.

Authors:  Fadil M Hannan; Enikö Kallay; Wenhan Chang; Maria Luisa Brandi; Rajesh V Thakker
Journal:  Nat Rev Endocrinol       Date:  2018-12       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.